Search results
24 paź 2024 · MenACWY vaccines (Menveo ® and MenQuadfi ®) help protect against 4 serogroups of the bacteria that cause meningococcal disease: A, C, W, and Y. This type of vaccine is also known as a serogroup A, C, W, and Y, or quadrivalent, meningococcal vaccine.
- About Meningococcal Vaccines
Currently, there are 6 meningococcal vaccines licensed and...
- About Meningococcal Vaccines
Compare Menactra vs Menveo head-to-head with other drugs for uses, ratings, cost, side effects and interactions.
Meningococcal Vaccination. Indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135 in individuals. 0.5 mL/dose...
7 paź 2020 · Story Highlights. Three MenACWY vaccines are licensed for use in the United States: Menactra (for persons age 9 months to 55 years), Menveo (for those age 2 months to 55 years) and MenQuadfi...
Currently, there are 6 meningococcal vaccines licensed and available in the United States. Learn about the composition, types, immunogenicity, and effectiveness of these vaccines, as well as view package inserts, below.
24 paź 2024 · CDC recommends meningococcal vaccination for all adolescents. CDC also recommends meningococcal vaccination for children and adults at increased risk for meningococcal disease. Follow the recommended immunization schedule to ensure that your patients get the meningococcal vaccines that they need.
Menveo and Menactra contain the same antigens as Menomune, but the antigens are conjugated to a diphtheria toxoid polysaccharide–protein complex, resulting in anticipated enhanced duration of protection, increased immunity with booster vaccinations, and effective herd immunity.
